Document is current
Any future updates will be listed below
-
Authors
Huynh, Victoria D.
Mouabbi, Jason
Kuerer, Henry M.
Wanis, Kerollos Nashat
Abdel-Salam, Hiam M.
Gutierrez, Angelica M.
Johnson, Helen M.
Lucci, Anthony
Hunt, Kelly K.
Arun, Banu K.
- License Information
-
More Information
Article History
Received: 24 January 2025
Accepted: 8 April 2025
First Online: 2 May 2025
Disclosures
: Dr. Kuerer reports receiving personal fees from NEJM Group Inc, UpToDate Inc, and McGraw-Hill Professional Inc outside the submitted work. Dr. Hunt reports personal fees from ArmadaHealth and AstraZeneca (medical advisory board) and Springer Nature (editor-in-chief of Current Breast Cancer Reports) and research funding to MD Anderson Cancer Center from Cairn Surgical, Eli Lilly & Co., and Lumicell. Dr. Mouabbi reports receiving personal fees from BostonGene, GE HealthCare, AstraZeneca, Aptitude Health, PreludeDX, and Community Health Media; grant support from Bristol Myers Squibb; and honoraria from Novartis, Gilead, Cardinal Health, Fresenius Kabi, Genentech, and OMNI Health. Dr. Mouabbi participates in the steering committee of AstraZeneca and Novartis and is the Scientific Advisory Board Chair of the Lobular Breast Cancer Alliance.
